Skip to content

STOP-COPD Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-502003-30-00
Enrollment
1888
Registered
2022-12-06
Start date
2024-12-11
Completion date
Unknown
Last updated
2024-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Brief summary

30-day mortality

Detailed description

24-hour mortality, 7-day mortality, Length of hospitalization, ICU admission rate, Length of ICU admission, In-hospital need for NIV within 24 hours, 7 days and 30 days, Time to NIV, In-hospital need for invasive mechanical ventilation within 24 hours, 7 days and 30 days, Time to invasive ventilation, Proportion of patients with respiratory acidosis on arrival to hospital, The degree of acidosis based on the pH-value, Patient experienced dyspnoea on a verbal rating scale 0-10, Readmission rate, Time to readmission

Interventions

DRUGopløsning
DRUGMedicinsk Luft ”Air Liquide” 100%
DRUGMedicinsk Oxygen ”Air Liquide” 100 %
DRUGmedicinsk gas komprimeret

Sponsors

Præhospitalet
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
30-day mortality

Secondary

MeasureTime frame
24-hour mortality, 7-day mortality, Length of hospitalization, ICU admission rate, Length of ICU admission, In-hospital need for NIV within 24 hours, 7 days and 30 days, Time to NIV, In-hospital need for invasive mechanical ventilation within 24 hours, 7 days and 30 days, Time to invasive ventilation, Proportion of patients with respiratory acidosis on arrival to hospital, The degree of acidosis based on the pH-value, Patient experienced dyspnoea on a verbal rating scale 0-10, Readmission rate, Time to readmission

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 9, 2026